Regulatory T cells in the antibody response to Haemophilus influenzae type b polysaccharide

Infection and Immunity

Volumn 67, Issue 2, 1999, Pages 789-793

  Breukels, Mijke A ^a   Rijkers, Ger T ^a   Voorhorst Ogink, Marleen M ^a   Zegers, Ben J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CYTOKINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN M; TETANUS TOXOID;

ADULT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE TYPE B; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE;

EID: 0032913656     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.2.789-793.1999     Document Type: Article

References (20)

1. Amlot, P. L., D. Grennan, and J. H. Humphrey. 1985. Splenic dependence of the antibody response to thymus independent (TI-2) antigens. Eur. J. Immunol. 15:508-512.
2. Austrian, R. 1989. Pneumococcal polysaccharide vaccines. Rev. Infect. Dis. 11(Suppl. 3):S598-S602.
3. Baker, P. J. 1992. T cell regulation of the antibody response to bacterial polysaccharide antigens: an examination of some general characteristics and their implications. J. Infect. Dis. 165(Suppl. 1):S44-S48.
4. Black, S. B., H. R. Shinefield, B. Fireman, R. Hiatt, M. Polen, and E. Vittinghoff. 1991. Efficacy in infancy of oligosaccharide Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. Pediatr. Infect. Dis. 10:97-104.
5. Cowan, M. J., A. J. Ammann, D. W. Wara, V. M. Howie, L. Schultz, N. Doyle, and M. Kaplan. 1978. Pneumococcal polysaccharide immunization in infants and children. Pediatrics 62:721-727.
6. Douglas, R. M., J. C. Paton, S. J. Duncan, and D. J. Hansman. 1983. Antibody response to pneumococcal vaccination in children younger than five years of age. J. Infect. Dis. 148:131-137.
7. Eskola, J., H. Käyhty, A. K. Takala, H. Peltola, P. Rönnberg, E. Kela, E. Pekkanen, P. H. McVerry, and P. H. Mäkelä. 1990. A randomized prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type B disease. N. Engl. J. Med. 323:1381-1387.
8. Eskola, J., H. Peltola, P. Makela, et al. 1985. Antibody levels achieved in infants by course of Haemophilus influenzae type b/diphtheria toxoid conjugate vaccine. Lancet i:1184-1186.
9. Griffioen, A. W., G. T. Rijkers, P. Janssens-Korpela, and B. J. M. Zegers. 1991. Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2. Infect. Immun. 59:1839-1845.
10. Insel, R. A., A. Kittelberger, and P. Anderson. 1985. Isoelectric focusing of human antibody to the Haemophilus influenzae b capsular polysaccharide: restricted and identical spectrotypes in adults. J. Immunol. 135:2810-2816.
11. Käyhty, H., V. Karanko, H. Peltola, and P. H. Mäkelä. 1984. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Pediatrics 74:857-865.
12. Mosier, D. E., and A. J. Feeney. 1986. The physiology of B lymphocytes capable of generating antipolysaccharide antibody responses, p. 243-249. In R. Bell and G. Torrigiani, (ed.), Towards better carbohydrate vaccines. John Wiley & Sons, New York, N.Y.
13. Noelle, R. J., J. A. Ledbetter, and A. Aruffo. 1992. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol. Today 13:431-433.
14. Panina-Bordignon, P., A. Tan, S. Termijtelen, S. Demotz, G. Corradin, and A. Lanzavecchia. 1989. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19:2237.
15. Peeters, C. C., A. M. Tenbergen Meekes, C. J. Heijnen, J. T. Poolman, B. J. Zegers, and G. T. Rijkers. 1991. In vitro induction of a Haemophilus influenzae type b polysaccharide-specific antibody response in human peripheral blood lymphocytes of individuals recently vaccinated with an oligosaccharide-protein conjugate. J. Immunol. 147:4192-4199.
16. Peeters, C. C. A. M., A. M. Tenbergen-Meekes, J. T. Poolman, B. J. M. Zegers, and G. T. Rijkers. 1993. In vitro antibody response of human lymphocytes to the Haemophilus influenzae type b capsular polysaccharide. Springer Semin. Immunopathol. 15:247-258.
17. Rijkers, G. T., and D. E. Mosier. 1985. Pneumococcal polysaccharides induce antibody formation by human B-lymphocytes in vitro. J. Immunol. 135:1-4.
18. Rijkers, G. T., E. A. M. Sanders, M. A. Breukels, and B. J. M. Zegers. 1996. Responsiveness of infants to capsular polysaccharides: impact for vaccine development. Rev. Med. Microbiol. 7:3-12.
19. Sedgwick, J. D., and P. G. Holt. 1983. A solid phase immunoenzymatic technique for the enumeration of specific antibody secreting cells. J. Immunol. Methods 57:301-309.
20. Siber, G. R. 1994. Pneumococcal disease: prospects for a new generation of vaccines. Science 265:1385-1387.